Retatrutide is a next-generation tri-agonist peptide that simultaneously targets GLP-1, GIP, and glucagon receptors. As one of the most comprehensive metabolic modulators available for research, it is revolutionizing the study of obesity, lipid metabolism, and energy homeostasis. View Certificate